Chinese Journal of Dermatology ›› 2019, Vol. 52 ›› Issue (7): 475-480.doi: 10.3760/cma.j.issn.0412-4030.2019.07.006
• Original Articles • Previous Articles Next Articles
Su Beibei, Gan Quan, Gan Caibin
Received:
2018-09-26
Revised:
2019-04-04
Online:
2019-07-15
Published:
2019-07-01
Contact:
Su Beibei
E-mail:t109107@126.com
Su Beibei, Gan Quan, Gan Caibin. Effects of metformin on inflammatory status and phosphorylated Stat3 expression in lesions of a psoriasis?like mouse model[J].Chinese Journal of Dermatology, 2019, 52(7): 475-480.
[1] | Lowes MA, Bowcock AM, Krueger JG. Pathogenesis and therapy of psoriasis[J]. Nature, 2007,445(7130):866⁃873. doi: 10.1038/nature05663. |
[2] | O′Shea JJ, Shea JJ, Plenge R. JAK and STAT signaling molecules in immunoregulation and immune⁃mediated disease[J]. Immunity, 2012,36(4):542⁃550. doi: 10.1016/j.immuni.2012.03.014. |
[3] | Calautti E, Avalle L, Poli V. Psoriasis: a STAT3⁃centric view[J]. Int J Mol Sci, 2018, 19(1). pii: E171. doi: 10.3390/ijms19010171. |
[4] | Miyoshi K, Takaishi M, Nakajima K, et al. Stat3 as a therapeutic target for the treatment of psoriasis: a clinical feasibility study with STA⁃21, a Stat3 inhibitor[J]. J Invest Dermatol, 2011,131(1):108⁃117. doi: 10.1038/jid.2010.255. |
[5] | 高玉梅, 马伟元, 孙青. 二甲双胍在皮肤病治疗中的应用进展[J]. 中华皮肤科杂志, 2015,48(9):670⁃672. doi: 10.3760/cma.j.issn.0412⁃4030.2015.09.029. |
[6] | Yang Y, Jin G, Liu H, et al. Metformin inhibits esophageal squamous cell carcinoma⁃induced angiogenesis by suppressing JAKSTAT3 signaling pathway[J]. Oncotarget, 2017,8(43):74673⁃ 74687. |
[7] | Yue W, Lin Y, Chen C, et al. Abstract 2153: metformin and aspirin synergistically inhibit mTOR and JAKSTAT3 signaling pathway and induce cell death in pancreatic cancer cells[J].Cancer Res, 2014,74(19 Supplement):2153. doi: 10.1158/1538⁃7445.AM2014⁃2153. |
[8] | Palamara F, Meindl S, Holcmann M, et al. Identification and characterization of pDC⁃like cells in normal mouse skin and melanomas treated with imiquimod[J]. J Immunol, 2004,173(5):3051⁃3061. |
[9] | Sano S, Chan KS, Carbajal S, et al. Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model[J]. Nat Med, 2005,11(1):43⁃49. doi: 10.1038/nm1162. |
[10] | 冉立伟, 兰东, 贾红侠. 寻常性银屑病皮损中STAT3的表达及磷酸化STAT3的水平[J]. 中国皮肤性病学杂志, 2011,25(9):675⁃677. |
[11] | Brauchli YB, Jick SS, Curtin F, et al. Association between use of thiazolidinediones or other oral antidiabetics and psoriasis: a population based case⁃control study[J]. J Am Acad Dermatol, 2008,58(3):421⁃429. doi: 10.1016/j.jaad.2007.11.023. |
[12] | Wu CY, Shieh JJ, Shen JL, et al. Association between antidiabetic drugs and psoriasis risk in diabetic patients: results from a nationwide nested case⁃control study in Taiwan[J]. J Am Acad Dermatol, 2015,72(1):123⁃130. doi: 10.1016/j.jaad.2014.08.042. |
[13] | Singh S, Bhansali A. Randomized placebo control study of metformin in psoriasis patients with metabolic syndrome (Systemic Treatment Cohort)[J]. Indian J Endocrinol Metab, 2017,21(4):581⁃587. doi: 10.4103/ijem.IJEM_46_17. |
[14] | Li W, Ma W, Zhong H, et al. Metformin inhibits proliferation of human keratinocytes through a mechanism associated with activation of the MAPK signaling pathway[J]. Exp Ther Med,2014,7(2):389⁃392. doi: 10.3892/etm.2013.1416. |
[15] | Liu Y, Yang F, Ma W, et al. Metformin inhibits proliferation and proinflammatory cytokines of human keratinocytes in vitro via mTOR⁃signaling pathway[J]. Pharm Biol, 2015,54(7):1173⁃1178. doi: 10.3109/13880209.2015.1057652. |
[16] | Wang X, Li R, Zhao X, et al. Metformin promotes HaCaT cell apoptosis through generation of reactive oxygen species via, Raf⁃1⁃ERK12⁃Nrf2 inactivation[J]. Inflammation, 2018,41(7429):1⁃11. doi: 10.1007/s10753⁃017⁃0657⁃7. |
[17] | Kerns ML, Hakim JM, Lu RG, et al. Oxidative stress and dysfunctional NRF2 underlie pachyonychia congenita phenotypes[J]. J Clin Invest, 2016,126(6):2356⁃2366. |
[18] | 卢博, 桂书彦, 周欢欢, 等. 二甲双胍抑制多发性骨髓瘤细胞增殖作用的实验研究[J]. 中国实验血液学杂志, 2017,25(4):1097⁃1100. doi: 10.7534/j.issn.1009⁃2137.2017.04.024. |
[19] | Isoda K, Young JL, Zirlik A, et al. Metformin inhibits proinflammatory responses and nuclear factor⁃kappaB in human vascular wall cells[J]. Arterioscler Thromb Vasc Biol, 2006,26(3):611⁃617. doi: 10.1161/01.ATV.0000201938.78044.75. |
[20] | Araújo AA, ASBF P, CACX M, et al. Effects of metformin on inflammation, oxidative stress, and bone loss in a rat model of periodontitis[J/OL]. PLoS One, 2017,12(8):e0183506. [2018⁃05⁃01]. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0183506. doi: 10.1371/journal.pone.0183506. |
[21] | 江萌, 马伟元, 孙青. 二甲双胍对HaCaT细胞增殖及miR⁃21⁃5p和PDCD4表达的影响[J]. 中华皮肤科杂志, 2015,48(3):200⁃203. doi: 10.3760/cma.j.issn.0412⁃4030.2015.03.017. |
[22] | 宋翠豪, 王睿, 陈双景, 等. 二甲双胍对HaCaT细胞增殖分化和炎症因子分泌的影响[J]. 中华皮肤科杂志, 2019,52(1):25⁃32. doi: 10.3760/cma.j.issn.0412⁃4030.2019.01.006. |
[1] | Chen Yiwen, Su Ting, Su Zhonglan. Association between psoriasis and STAT3 [J]. Chinese Journal of Dermatology, 2019, 52(7): 502-505. |
[2] | Qin Hui, Zheng Jie. FTY720 ameliorates psoriasis by inhibiting infiltration of skin Interleukin 17-producing γδT cells [J]. Chinese Journal of Dermatology, 2019, 52(6): 395-400. |
[3] | Wang Liwei, Luo Lingling, Cui Pan′gen, Li Min. Relationship between intestinal flora and psoriasis [J]. Chinese Journal of Dermatology, 2019, 52(5): 357-360. |
[4] | Hu Yu, Chen Min, Gu Heng. MicroRNA and lncRNA in psoriasis [J]. Chinese Journal of Dermatology, 2019, 52(5): 350-353. |
[5] | Pan Jiaxu, Zhou Jing. NF?κB signaling pathway in psoriasis [J]. Chinese Journal of Dermatology, 2019, 52(5): 361-363. |
[6] | Zeng Jingxin, Tian Xin, Zhu Huilan, Zhang Xibao, Lin Ling, Zhang Lidan, Liu Weiyu, Luo Quan . Expression of miRNA-148a-3p in CD4+ T lymphocytes in peripheral blood of patients with psoriasis vulgaris and its clinical significance [J]. Chinese Journal of Dermatology, 2019, 52(4): 231-235. |
[7] | Committee on Psoriasis, Chinese Society of Dermatology. Guideline for the diagnosis and treatment of psoriasis in China (2018 simplified edition) [J]. Chinese Journal of Dermatology, 2019, 52(4): 223-230. |
[8] | Working Committee on Standardized Diagnosis and Treatment, China Dermatologist Association, Dermatological Surgical Equipment Group and Skin Phototherapy Group, Committee on Skin Disease and Cosmetic Dermatology, China Association of Medical Equipment. Clinical application of home narrow band ultraviolet B phototherapy: an expert consensus statement [J]. Chinese Journal of Dermatology, 2019, 52(3): 156-161. |
[9] | Gao Yimeng, Jin Hongzhong. The role of neuropsychiatric factors in the occurrence of psoriasis [J]. Chinese Journal of Dermatology, 2019, 52(3): 204-207. |
[10] | WANG Gang. Main adverse reactions in biological agents in dermatology and their strategies [J]. Chinese Journal of Dermatology, 2019, 52(2): 77-80. |
[11] | Guan Xin, Zhang Chunlei. Evaluation of efficacy of infliximab in the long-term treatment of moderate and severe psoriasis vulgaris [J]. Chinese Journal of Dermatology, 2019, 52(2): 86-89. |
[12] | Hu Yu, Luan Chao, Lian Ni, Hao Zhimin, Sun Yujie, Wang Yan, Gu Heng, Chen Min. Expression of proprotein convertase subtilisin/kexin type 9 in the plasma of patients with psoriasis and its effect on the activation of peripheral CD4+ T cells [J]. Chinese Journal of Dermatology, 2019, 52(2): 90-93. |
[13] | Peng Chen, Chen Wenjuan, Yu Ning, Gao Yunlu, Yi Xuemei, Ding Yangfeng. The progress of relationship between psoriasis and microecology of skin and intestine [J]. Chinese Journal of Dermatology, 2019, 52(2): 135-137. |
[14] | Xiong Juanjuan, Bi Jianping, Sun Dexiang, Li Nian, Lu Qiaoyun. Dermoscopic features of onychomycosis and nail psoriasis [J]. Chinese Journal of Dermatology, 2019, 52(2): 106-110. |
[15] | Zhang Nan, Wang Lian, Liu Lian, Zhang Zihui, Jiang Xian. Effect of atopic dermatitis-related cytokines on skin barrier [J]. Chinese Journal of Dermatology, 2019, 52(1): 46-49. |
|